Norges Bank’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-4,200	Closed	-$60K	–	2151
2016 Q2	$60K	Sell	4,200 -15,800	-79%	-$226K	﹤0.01%	2170
2016 Q1	$290K	Buy	+20,000	New	+$290K	﹤0.01%	2157